Reuters logo
BRIEF-Antares Pharma Q3 loss per share $0.03
2017年11月7日 / 中午12点24分 / 15 天前

BRIEF-Antares Pharma Q3 loss per share $0.03

Nov 7 (Reuters) - Antares Pharma Inc

* Antares Pharma reports third quarter 2017 operating and financial results

* Q3 loss per share $0.03

* Q3 revenue $15.1 million versus I/B/E/S view $14 million

* Q3 earnings per share view $-0.03 -- Thomson Reuters I/B/E/S

* Antares Pharma - ‍at September 30, 2017, cash, cash equivalents and short-term investments were $37.4 million compared to $27.7 million at December 31, 2016​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below